Trump administration moves forward with certain drug reclassifications

President Trump signed an executive order to advance research on psychedelics for mental illness treatment. This follows his 2025 reclassification of marijuana as a less dangerous drug. Josh Kesselman, founder of RAW rolling papers and publisher of High Times Magazine, is among those supporting the move.